Dynavax Technologies | I Saldi





I Saldi Cambiamento Data
AbbVie USD 16.62B 840M 2025-12
Adma Biologics USD 134.22M 12.24M 2025-09
Agenus USD 24.07M 2.77M 2025-03
Amgen USD 9.9B 340M 2025-12
AstraZeneca USD 15.5B 313M 2025-12
Biogen USD 2.28B 250M 2025-12
BioMarin Pharmaceutical USD 776M 49M 2025-09
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Dynavax Technologies USD 94.9M 540K 2025-09
Gilead Sciences USD 7.93B 130M 2025-12
Glaxosmithkline GBP 11.52B 3.54B 2025-09
Merck USD 16.4B 880M 2025-12
Minerva Neurosciences USD 0 0 2024-09
Nektar Therapeutics USD 24.12M 635K 2024-09
Neurocrine Biosciences USD 805.5M 10.6M 2025-12
Novartis USD 13.91B 144M 2025-09
Pfizer USD 17.58B 880M 2025-12
Regeneron Pharmaceuticals USD 3.88B 130M 2025-12
Roche Holding CHF 15.65B 274.5M 2025-12
Sarepta Therapeutics USD 399.4M 211.69M 2025-09
TG Therapeutics USD 161.7M 20.6M 2025-09
Vertex Pharmaceuticals USD 3.08B 120M 2025-09


Dynavax Technologies I Saldi - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.